Recomienda este artículo a tus amigos:
Target Validation in Drug Discovery
Dillon
Target Validation in Drug Discovery
Dillon
Presents a comprehensive framework for approaching target validation in drug discovery. This work begins with a description of enabling technologies, including aptamers, RNA interference, and proteomics. It, then, looks at biologic drug development with discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin.
296 pages, Illustrated
Medios de comunicación | Libros Hardcover Book (Libro con lomo y cubierta duros) |
Publicado | 1 de septiembre de 2006 |
ISBN13 | 9780123693938 |
Editores | Elsevier Science Publishing Co Inc |
Páginas | 296 |
Dimensiones | 184 × 260 × 24 mm · 820 g |
Editor | Dillon, Susan (Senior Vice President, Discovery Research Centocor, Johnson & Johnson, Malvern, PA, U.S.A.) |
Editor | Metcalf, Brian W. (Chief Drug Discovery Officer, Incyte Corporation, Moraga, CA, U.S.A.) |
Mostrar todo
Mas por Dillon
Otros también han comprado
Ver todo de Dillon ( Ej. Book , CD , LP , Hardcover Book y Paperback Book )